Prices delayed by at least 15 minutes | Print
Lunglife Ai, INC (LLAI)
ORD USD0.0001 (DI)Open
26.5p
Previous close
26.5p
Trade high
26.7p
Volume
122,013
Year high
142.10p
Year low
19.00p
Dividend yield
-
Market capitalisation
£7.97 mn
P/E ratio
-
ISIN
USU5500L1045
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 03/05/2024 | 03:46:03 | 26.7 | 75,198 | 20,077.87 |
| 03/05/2024 | 03:39:27 | 25.2 | 7,671 | 1,933.09 |
| 03/05/2024 | 03:19:51 | 25.2 | 2,500 | 630.00 |
| 03/05/2024 | 09:39:17 | 26.222 | 3,798 | 995.91 |
| 03/05/2024 | 09:20:02 | 25 | 12,273 | 3,068.25 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.